Torrent Pharma, one of the leading pharma companies of the country has commenced commercial operations at its new plant in Dahej. This is the company's 5th formulation plant and the second API plant. The facility is being set up in a two phases. The total investment made in the first phase of the plant is over Rs 650 crore.
The new plant, situated in Dahej SEZ is spread across 70 acres site with a built up area of around 97000 Square Meters. Phase I will have installed capacity of about 7,500 million tablets / capsules and 25 MT API per annum. The plant will cater mainly to the more regulated international markets such as US, Brazil, Germany etc. and is already approved / under approval by regulatory authorities of these countries. Construction of Phase II will commence soon and once commissioned the total capacity will increase to about 14,000 million tablets / capsules and 80 MT API per year.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
